Healthcare Strategies

A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost. 

Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.

Subscribe on iTunes, Spotify

Listen on Apple Podcasts

Featured

Episode Date
S06E14

Episode S06E14: 2025 predictions: GLP-1s, telehealth, AI, employer health plans, and more

2025 promises to be an interesting year in healthcare with many possibilities, challenges and unknowns. A few of our editorial staff members got together to discuss the trends we will be watching in the new year, from telehealth flexibilities to artificial intelligence guardrails, and from employers' cost-cutting efforts to the future of reproductive health.

Featuring: Shania Kennedy, assistant editor of Healthtech Analytics at Xtelligent

Veronica Salib, associate editor of Pharma Life Sciences at Xtelligent Healthcare

Anuja Vaidya, senior editor of Virtual Healthcare and special events lead at Xtelligent Healthcare

Kelsey Waddill, multimedia manager and managing editor of Healthcare Payers at Xtelligent Healthcare

In today’s episode, we’ll cover…

  • The focal points of GLP-1 research in the coming year
  • GLP-1 coverage expectations
  • AI trends in 2025
  • Telehealth market shifts
  • Reproductive healthcare evolution since the overturn of Roe v. Wade

...and more!

To learn more about 2025 healthcare industry predictions, check out our Xtelligent sites: Healthtech Analytics, Healthcare Payers, Pharma Life Sciences, and Virtual Healthcare.
To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

Thank you to Dr. Sanjula Jain, Melissa Knuth, and Dr. Stephanie Page who spoke with us earlier in the season and whose insights we included in this episode.


References

GLP-1 general impact overview https://www.techtarget.com/pharmalifesciences/feature/Anticipating-the-healthcare-reach-of-GLP-1-receptor-agonists

CDC unintended pregnancy data https://www.cdc.gov/reproductive-health/hcp/unintended-pregnancy/index.html#:~:text=Overview,2010%20to%2041.6%25%20in%202019

Vasectomy data from the University of Florida Health https://ufhealth.org/stories/2022/what-to-know-before-getting-a-vasectomy

Planned Parenthood data on vasectomy reversals https://www.plannedparenthood.org/blog/are-vasectomies-reversible#

HR managers see value in GLP-1 coverage https://ir.accolade.com/news-releases/news-release-details/glp-1-coverage-employer-plans-could-nearly-double-2024

Employer coverage rates of GLP-1s for weight loss https://www.ifebp.org/resources---news/survey-reports/glp-1-drugs--2024-pulse-survey-report-(u.s.-corporate-data)

Exploring generative AI in healthcare https://www.techtarget.com/healthtechanalytics/feature/Exploring-generative-artificial-intelligence-in-healthcare

Introducing the role of Chief Analytics Officer https://www.techtarget.com/healthtechanalytics/answer/Exploring-the-Role-of-Cleveland-Clinics-First-Chief-Analytics-Officer

Telehealth volumes data from Trilliant Health https://www.techtarget.com/virtualhealthcare/answer/Examining-the-limitations-of-the-current-telehealth-market

Leveraging RPM at home for cancer care https://www.techtarget.com/virtualhealthcare/feature/Leveraging-RPM-to-Enable-At-Home-Care-for-High-Risk-Cancer-Patients

Vendor uses wearables to assess impact of GLP-1s on Parkinson's disease https://www.statnews.com/2024/12/10/glp-1-parkinsons-health-tech-startup-koneksa-digital-measures/ 

1/6/25
S06E13

Episode S06E13: Understanding pharmacists’ role in contraceptive access

As the reproductive health landscape continues to evolve, access to contraception and prescriptions for contraception are increasingly critical tools for preventing unplanned pregnancies. In some states, pharmacists at retail pharmacies can play a critical role in contraceptive access by providing counseling and prescriptions for some birth control methods.

Featuring: Dr. Mollie Scott, a pharmacist, the regional associate dean of the University of North Carolina Eshelman School of Pharmacy, and Chair of the Department of Pharmacotherapy at Mountain Area Health Education Center.

In today’s episode, we’ll cover

  • The role pharmacists play in prescribing and medication management
  • Policies and regulations for pharmacists’ prescribing
  • The benefits and drawbacks of pharmacists prescribing contraception
  • Advocacy tips for pharmacists hoping to change contraception prescribing laws in their state

And more!

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

Note: The Healthcare Strategies team will be on break for 12/30/24, but make sure to tune in for our first episode of the new year (publishing 1/6/25) where we cover major trends for 2025!

Resources:

Clinical Pharmacists Are a Major Contributor to Quality Patient Care https://www.techtarget.com/pharmalifesciences/feature/Clinical-Pharmacists-Are-a-Major-Contributor-to-Quality-Patient-Care

Understanding the widespread impacts of pharmacy deserts https://www.techtarget.com/pharmalifesciences/answer/Understanding-the-widespread-impacts-of-pharmacy-deserts

Limited Access to Female Contraceptives: A Public Health Crisis https://www.techtarget.com/pharmalifesciences/feature/Limited-Access-to-Female-Contraceptives-A-Public-Health-Crisis

Assessing the Expected Impacts of OTC Hormonal Birth Control Pills https://www.techtarget.com/pharmalifesciences/feature/Assessing-the-Expected-Impacts-of-OTC-Hormonal-Birth-Control-Pills 

12/23/24
S06E12

Episode S06E12: Exploring key telehealth policy considerations for 2025

The future of telehealth policy remains uncertain, with pandemic-era regulatory flexibilities set to expire by the end of the year, barring Congressional action. What is holding Congress back from extending or solidifying these flexibilities, and will those concerns influence telehealth legislation in 2025?

Featuring: Darryl Roberts, Vice President of Health Informatics at RELI Group

In today's episode, we'll cover…

  • The impact of telehealth flexibilities on healthcare delivery and patient outcomes  
  • Possible reasons why Congress has yet to act despite bipartisan support for telehealth access
  • Key pieces of legislation to watch for in 2025

References:

Spending Bill to Extend Telehealth, Hospital-at-Home Waivers for 2 Years (https://www.techtarget.com/virtualhealthcare/news/366596488/Spending-Bill-to-Extend-Telehealth-Hospital-at-Home-Waivers-for-2-Years)

HHS: How the End of the PHE Will Impact Telehealth Flexibilities (https://www.techtarget.com/virtualhealthcare/news/366596867/HHS-How-the-End-of-the-PHE-Will-Impact-Telehealth-Flexibilities)

What the NJ Lawsuit Adds to Out-of-State Telehealth, Licensure Debates (https://www.techtarget.com/virtualhealthcare/answer/What-the-NJ-Lawsuit-Adds-to-Out-of-State-Telehealth-Licensure-Debates)

What the House subcommittee hearing tells us about telehealth’s future (https://www.techtarget.com/virtualhealthcare/feature/What-the-House-subcommittee-hearing-tells-us-about-telehealths-future)

To learn more about telehealth policy, check out our site, Xtelligent Virtual Healthcare.

To watch video clips from our podcast, subscribe to our YouTube channel, @HealthcareStrategies.

12/16/24
S6E11

Episode S6E11: Regulating and monitoring the online GLP-1 market

GLP-1 (glucagon-like peptide 1) medications are revolutionizing weight loss and diabetes care, but behind the hype lies a growing web of regulatory gaps, telehealth expansion and online pharmacy risks. This episode unpacks the opportunities -- and dangers -- shaping the future of these life-changing drugs. 

Featuring: Scott Roth, Chief Executive Officer, LegitScript

Gerard Olsen, Director of Research, LegitScript

In today’s episode, we'll cover…

  • The skyrocketing demand for GLP-1 medications and their influence on weight loss trends, including a 26% drop in bariatric surgeries
  • How telehealth and online pharmacies are reshaping access to GLP-1 drugs -- and the risks posed by rogue sellers and counterfeit products
  • The critical need for stronger regulatory enforcement and LegitScript's role in ensuring safety and transparency in the online healthcare market

 To learn more about GLP-1 medications from all angles, check out our Pharma Life Sciences, Patient Engagement and Healthcare Payers sites.

To watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.

References:

Metabolic bariatric surgery in the GLP-1 era (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825349)

Risks of online semaglutide without prescription (https://www.techtarget.com/pharmalifesciences/news/366609735/Study-uncovers-risks-of-buying-semaglutide-online)

FDA updates on GLP-1 compounding policies (https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize)

12/9/24
‹ First  < 4 5 6 7 8 >  Last ›

Conversion Pixel